KM Research Hub
← 返回结果库查看论文详情PubMed ↗
READ-ONLY DIGITIZATION RESULT

A phase 3 study of intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.

Blood · 2026-Apr-09 · PMID 41490515

Panel D质量警告待 EXE 对齐验证

EFS

Figure 3. Prespecified subgroup analyses for the primary end point EFS by treatment arm and according to patient subgroups. (A) According to KIT mutation status, mutated vs wt. (B) According to type of CBF-AML, inv(16) vs t(8;21). (C) According to age group, 18 to 60 years vs >60 years. (D) According to sex, male vs female.

算法:legacy-0.5.0引擎:enhanced-linux
质量评分0.58
质量通过否
预期曲线2
实际曲线1
X 范围0 – 10
Y 范围-

曲线数据

网页最多预览 200 行,完整数据请下载 CSV 或 JSON。

匹配 22 行
Curve序号X (norm)Y (norm)X (real)Y (real)X (pixel)Y (pixel)
110.00000.29410.00005236
120.04710.29410.00006536
130.05070.29410.04056636
140.05430.29410.08106736
150.05800.29410.12156836
160.06160.29410.16196936
170.06520.31370.20247035
180.09060.25490.48587738
190.09420.25490.52637838
1100.09780.25490.56687938
1110.10140.25490.60738038
1120.10510.25490.64788138
1130.10870.25490.68838238
1140.11230.25490.72878338
1150.14860.25491.13369338
1160.15220.25491.17419438
1170.15580.25491.21469538
1180.15940.25491.25519638
1190.16300.25491.29559738
1200.16670.25491.33609838
1210.17750.25491.457510138
1220.19200.25491.619410538
历史版本(1)

重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。

版本状态验证曲线时间
legacy-0.5.0quality_warning待验证12026-07-24T15:14:24+00:00